A comprehensive immunological analysis in chronic fatigue syndrome.
Gupta, S, Vayuvegula, B · Scandinavian journal of immunology · 1991 · DOI
Quick Summary
Researchers compared immune system cells and antibodies in 20 ME/CFS patients and 20 healthy people to see if there were differences. They found that ME/CFS patients had fewer natural killer cells (immune cells that fight infections), some changes in how their immune cells communicate with each other, and weaker responses to certain types of immune challenges. These findings suggest the immune system works differently in ME/CFS.
Why It Matters
This study provides early evidence that ME/CFS involves measurable immune dysfunction rather than being purely psychological, which was controversial in the 1990s. Identifying specific immune abnormalities—particularly natural killer cell deficiency and impaired antigen responses—helps establish biological markers that could eventually support diagnosis and guide treatment development.
Observed Findings
Natural killer cells were significantly reduced in ME/CFS patients compared to controls.
CD4+ T cells with increased ICAM-1 expression were present in higher proportions in ME/CFS patients.
Monocytes from ME/CFS patients showed higher expression of ICAM-1 and LFA-1 but lower response to interferon-gamma stimulation.
Lymphocyte responses to soluble antigens were significantly reduced in ME/CFS despite normal responses to mitogens.
40% of ME/CFS patients had anti-HHV-6 antibody titers elevated above control levels (≥1/80).
Inferred Conclusions
ME/CFS is associated with measurable immunological dysfunction affecting both cellular and humoral immunity.
Weakened antibody responses to vaccination and elevated HHV-6 serology suggest potential viral reactivation or immune dysregulation in ME/CFS.
Immune dysfunction in ME/CFS affects multiple compartments of the immune system including T cells, monocytes, and natural killer cells.
Remaining Questions
Do these immune abnormalities precede ME/CFS onset or develop as a consequence of the illness?
What This Study Does Not Prove
This study does not prove that immune abnormalities *cause* ME/CFS or that correcting them will resolve the disease. Cross-sectional comparison cannot determine whether observed immune changes are primary drivers of ME/CFS or secondary consequences of chronic illness. The elevated anti-HHV-6 antibodies do not prove HHV-6 causes ME/CFS, only that exposure or reactivation may be more common.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →